Oramed Pharmaceuticals Inc. is guided by a diverse Board of Directors comprising experienced biopharmaceutical executives, medical researchers, and corporate governance specialists. Key members steering the clinical-stage pharmaceutical enterprise include Dr. Miriam Kidron (Chief Scientific Officer and co-founder), Nadav Kidron (President and CEO), Kevin Duffy, Leonard Sank, and independent directors who provide fiduciary oversight, strategic direction, and regulatory guidance for its oral insulin and oral drug delivery technology platforms.